Lab
Diagnostic Laboratory Solutions
Diagnostic Laboratory Solutions was paid $12K by Medicaid between Jun 2023 and Oct 2024, across 6 billing codes. Its largest line is 87637, Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV — 66% of everything it billed.
33Billing provider infoDIAGNOSTIC LABORATORY SOLUTIONS
DALLAS, TX 75204
DALLAS, TX 75204
33aNPI1063966745assigned 08/10/2016
33bProvider typeClinical Medical Laboratory
28Total paid$12K
24GClaims1,473
24DCodes billed6
24AFirst – last monthJun 2023 – Oct 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Texas
Rank by total paid#228 of 436
Median peer was paid$17K
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 403 | $307.40 | |
| 2024incomplete | 1,070 | $12K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 66% | 253 | 95 | $8K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 18% | 485 | 173 | $2K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 8.8% | 225 | 78 | $1K |
| 87581 | 4.5% | 222 | 76 | $548.74 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.5% | 174 | 90 | $307.40 |
| 87631 | <1% | 114 | 41 | $109.92 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDEL SIGNORE, JOSEPH (CEO)
| Provider | Location | Paid |
|---|---|---|
| Nextgen Laboratories, INC. | Newport Beach, CA | $7.65M |
| Ohana Genetics INC | Honolulu, HI | $22K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.